Gene · 599
Papers4,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 4,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37627215 | PubTator, text mining | PubMed |
| Management of Obesity-Related Inflammatory and Cardiovascular Diseases by Medicinal Plants: From Traditional Uses to Therapeutic Targets. | Biomedicines | 2023 | 37626701 | PubTator, text mining | PubMed |
| Targeting MCL-1 protein to treat cancer: opportunities and challenges. | Front Oncol | 2023 | 37601693 | PubTator, text mining | PubMed |
| Chinese giant salamander Bcl-w: An inhibitory role in iridovirus-induced mitochondrial apoptosis and virus replication. | Virus Res | 2023 | 37597665 | PubTator, text mining | PubMed |
| Advances in the Application of Apoptotic Proteins and Alternative Splicing in Tumor Therapy: A Narrative Review. | Iran J Public Health | 2023 | 37593500 | PubTator, text mining | PubMed |
Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. | BMC Cancer | 2023 | 37592239 | PubTator, text mining | PubMed |
| Drug Development from Natural Products Based on the Pathogenic Mechanism of Asthma. | Int J Mol Sci | 2023 | 37569846 | PubTator, text mining | PubMed |
| Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease. | Int J Mol Sci | 2023 | 37569812 | PubTator, text mining | PubMed |
| BCL-W makes only minor contributions to MYC-driven lymphoma development. | Oncogene | 2023 | 37567974 | PubTator, text mining | PubMed |
| Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies. | Glob Med Genet | 2023 | 37565061 | PubTator, text mining | PubMed |
| Unraveling the Complexity of Regulated Cell Death in Esophageal Cancer: from Underlying Mechanisms to Targeted Therapeutics. | Int J Biol Sci | 2023 | 37564206 | PubTator, text mining | PubMed |
| Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis. | Int J Biol Sci | 2023 | 37564197 | PubTator, text mining | PubMed |
| Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids. | Front Endocrinol (Lausanne) | 2023 | 37560308 | PubTator, text mining | PubMed |
| Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival Bcl-2 family proteins. | Comput Struct Biotechnol J | 2023 | 37560128 | PubTator, text mining | PubMed |
| Strategies for senolytic drug discovery. | Aging Cell | 2023 | 37548098 | PubTator, text mining | PubMed |
| Different types of cell death and their shift in shaping disease. | Cell Death Discov | 2023 | 37542066 | PubTator, text mining | PubMed |
| Targeting Bcl-xL is a potential therapeutic strategy for extranodal NK/T cell lymphoma. | iScience | 2023 | 37539026 | PubTator, text mining | PubMed |
| GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1. | J Transl Med | 2023 | 37537694 | PubTator, text mining | PubMed |
| Structural Characterization and Anticancer Activity of a New Anthraquinone from Senna velutina (Fabaceae). | Pharmaceuticals (Basel) | 2023 | 37513863 | PubTator, text mining | PubMed |
| Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection. | Molecules | 2023 | 37513286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/599/papers?page=10